Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 11, 2020 at 02:07 pm EST
Share
Universal Vision Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 600.007 million compared to TWD 362.629 million a year ago. Operating income was TWD 192.216 million compared to TWD 57.887 million a year ago. Net income was TWD 151.974 million compared to TWD 52.382 million a year ago. Basic earnings per share was TWD 2 compared to TWD 0.69 a year ago. Diluted earnings per share was TWD 1.99 compared to TWD 0.69 a year ago. For the nine months, sales was TWD 1,478.795 million compared to TWD 1,032.377 million a year ago. Operating income was TWD 434.499 million compared to TWD 175.610 million a year ago. Net income was TWD 356.322 million compared to TWD 172.461 million a year ago. Basic earnings per share was TWD 4.68 compared to TWD 2.27 a year ago. Diluted earnings per share was TWD 4.67 compared to TWD 2.26 a year ago.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. 
